Presentation is loading. Please wait.

Presentation is loading. Please wait.

Warfarin Pharmacogenetics: CYP2C9 and VKORC1 Genotypes Predict Different Sensitivity and Resistance Frequencies in the Ashkenazi and Sephardi Jewish.

Similar presentations


Presentation on theme: "Warfarin Pharmacogenetics: CYP2C9 and VKORC1 Genotypes Predict Different Sensitivity and Resistance Frequencies in the Ashkenazi and Sephardi Jewish."— Presentation transcript:

1 Warfarin Pharmacogenetics: CYP2C9 and VKORC1 Genotypes Predict Different Sensitivity and Resistance Frequencies in the Ashkenazi and Sephardi Jewish Populations  Stuart A. Scott, Lisa Edelmann, Ruth Kornreich, Robert J. Desnick  The American Journal of Human Genetics  Volume 82, Issue 2, Pages (February 2008) DOI: /j.ajhg Copyright © 2008 The American Society of Human Genetics Terms and Conditions

2 Figure 1 Schematic of the CYP2C9 and VKORC1 Genes
The locations of the nucleotide variations and missense mutations analyzed in this study are noted and are based on accession numbers M61857 and AY The g.-1639G→A (rs ), g.3730G→A (rs7294), and g.698C→T (rs ) tag-SNPs for the VKORC1∗2,∗3, and ∗4 haplotypes correspond to 3673G→A, 9041G→A, and 6009C→T (accession number AY587020), respectively. Illustrations are not to scale. The American Journal of Human Genetics  , DOI: ( /j.ajhg ) Copyright © 2008 The American Society of Human Genetics Terms and Conditions


Download ppt "Warfarin Pharmacogenetics: CYP2C9 and VKORC1 Genotypes Predict Different Sensitivity and Resistance Frequencies in the Ashkenazi and Sephardi Jewish."

Similar presentations


Ads by Google